| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | EP0882067B2 Methods of treating vascular disease with tnf antagonists |
| 04/22/2009 | EP0869775B1 Dietary fiber inulin delivery system |
| 04/22/2009 | CN201223619Y Multifunctional integrated anaesthesia equipment for skin |
| 04/22/2009 | CN101415825A MCP-1 binding nucleic acids |
| 04/22/2009 | CN101415732A Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 04/22/2009 | CN101415731A Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same |
| 04/22/2009 | CN101415720A 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 04/22/2009 | CN101415716A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/22/2009 | CN101415713A Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415712A Use of spiro imidazolidine-4, 3'-indole-2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415711A Novel spiro [imidazolidine-4, 3 '-indole] 2,2', 5' (1'H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415710A Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 04/22/2009 | CN101415709A Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| 04/22/2009 | CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 04/22/2009 | CN101415707A Heterobicyclic amide derivatives |
| 04/22/2009 | CN101415706A Azolopyridin-3-one derivatives as inhibitors of endothelial lipase |
| 04/22/2009 | CN101415705A Compounds and methods for inhibiting hepatitis c viral replication |
| 04/22/2009 | CN101415704A 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors |
| 04/22/2009 | CN101415703A Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415701A Heterocyclylacrylamide compounds as FABI inhibitors and antibacterial agents |
| 04/22/2009 | CN101415699A Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 04/22/2009 | CN101415695A Ceramide kinase modulation |
| 04/22/2009 | CN101415691A Triazole derivative |
| 04/22/2009 | CN101415690A Novel tricyclic dihydropyrazines as potassium channel openers |
| 04/22/2009 | CN101415689A Substituted quinazolines with anti-cancer activity |
| 04/22/2009 | CN101415688A Quinazolone derivative with B-RAF inhibition activity |
| 04/22/2009 | CN101415686A Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 04/22/2009 | CN101415685A Kinase inhibitors and methods of use thereof |
| 04/22/2009 | CN101415681A Pyridine and pyrimidine derivatives as mGluR2 antagonists |
| 04/22/2009 | CN101415680A Benzoisoindole derivatives for the treatment of pain |
| 04/22/2009 | CN101415679A Water-solubility CC-1065 analog and composition thereof |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101415464A Solid oral compositions based on s-adenosyl methionine and/or NADH and process for obtaining them |
| 04/22/2009 | CN101415443A Compositions of stabilized DNA for coating microprojctions |
| 04/22/2009 | CN101415440A Method for treating lung cancer |
| 04/22/2009 | CN101415431A A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 04/22/2009 | CN101415430A A pharmaceutical composition comprising oenothein C useful for the treatment of peptic ulcer diseases |
| 04/22/2009 | CN101415429A Fat accumulation inhibitor |
| 04/22/2009 | CN101415428A Novel formulations |
| 04/22/2009 | CN101415427A Methods for prevention and treatment of conditions arising from local estrogen deficiency |
| 04/22/2009 | CN101415426A Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 04/22/2009 | CN101415425A Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 04/22/2009 | CN101415424A Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer |
| 04/22/2009 | CN101415423A Spirocyclic heterocyclic derivatives and methods of their use |
| 04/22/2009 | CN101415422A Anti-cancer pharmaceutical composition |
| 04/22/2009 | CN101415421A Nanoparticle dispersion containing lactam compound |
| 04/22/2009 | CN101415420A Combinations of therapeutic agents for treating cancer |
| 04/22/2009 | CN101415419A Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 04/22/2009 | CN101415418A Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity |
| 04/22/2009 | CN101415417A Combination therapy of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro-1H-[1,2]diazepino[4,5,6-CD]indol-8-yl)acetamide |
| 04/22/2009 | CN101415416A Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same |
| 04/22/2009 | CN101415415A Methods and compositions of targeted drug development |
| 04/22/2009 | CN101415414A Treatments using citrulline |
| 04/22/2009 | CN101415413A Renin inhibitors for the treatment of hypertension |
| 04/22/2009 | CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 04/22/2009 | CN101415411A Combinations of therapeutic agents for treating cancer |
| 04/22/2009 | CN101415410A The use of bupropion metabolites for the treatment of inflammatory disorders |
| 04/22/2009 | CN101415409A Combinations of therapeutic agents for treating cancer |
| 04/22/2009 | CN101415408A Milk oligosaccharides for stimulating immune system |
| 04/22/2009 | CN101415407A Use of inhibitors of JUN N-terminal kinases to treat glaucoma |
| 04/22/2009 | CN101415405A Swellable particles for drug delivery |
| 04/22/2009 | CN101415404A A tablet of paracetamol containing an encapsulated flavorant |
| 04/22/2009 | CN101415402A UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an uv-absorbing component |
| 04/22/2009 | CN101415341A Formulation containing a polyphenol-containing composition and isomaltulose |
| 04/22/2009 | CN101415328A Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
| 04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/22/2009 | CN101412744A Anti-angiogenic compositions and methods of use thereof |
| 04/22/2009 | CN101412743A 2 alpha-hydroxy-substituted white birch keto acid, preparation thereof and anti-tumor use |
| 04/22/2009 | CN101412742A Nitric acid ester medicament for inhibiting angiogenesis |
| 04/22/2009 | CN101412741A Composition with methylprednisolone palmitate as active component for treating local inflammation |
| 04/22/2009 | CN101412740A Hydrate of azithromycin, and preparation and use thereof |
| 04/22/2009 | CN101412737A Anti-tumor bipyridine methyl substituted manganese amino acid complex, and preparation and application thereof |
| 04/22/2009 | CN101412729A Penem compounds and preparation thereof |
| 04/22/2009 | CN101412726A Novel heterocyclic compounds |
| 04/22/2009 | CN101412720A Carbapenem compound containing mercapto nitrogen heterocyclic vinyl |
| 04/22/2009 | CN101412719A Carbapenem derivatives |
| 04/22/2009 | CN101412718A Carbapenem derivative containing sulfenyl heterocyclic amine formyl |
| 04/22/2009 | CN101412717A Carbapenem derivative containing guanidyl alkanoylamino heterocycle |
| 04/22/2009 | CN101412714A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 04/22/2009 | CN101412713A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 04/22/2009 | CN101412711A Carbamate derivatives and use thereof in medicine |
| 04/22/2009 | CN101412709A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 04/22/2009 | CN101412708A Duloxetine derivative and preparation thereof |
| 04/22/2009 | CN101412707A Duloxetine derivative and preparation thereof |
| 04/22/2009 | CN101412700A Crystal form and preparation of febuxostat |
| 04/22/2009 | CN101412696A 4,5-diaryl pyrazole-3-amido derivative, and preparation and use thereof |
| 04/22/2009 | CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof |
| 04/22/2009 | CN101412690A Medicinal acid addition salt of silodosin, and preparation and medicament use thereof |
| 04/22/2009 | CN101411877A Method for preparing thermosensitive nano medicament carrier with dual-target magnetism and folacin |
| 04/22/2009 | CN101411853A Health care medical pillow for strengthening brain and inducing resuscitation |
| 04/22/2009 | CN101411847A Medicinal composition for treating hepatitis and preparation method thereof |
| 04/22/2009 | CN101411845A Cancer-suppressing analgesic medicament |
| 04/22/2009 | CN101411838A Chinese herbal compound formulation for treating vulvovaginitis and venereal disease, and preparation method thereof |
| 04/22/2009 | CN101411837A Chinese medicine external-use tinctura for treating athlete's foot |
| 04/22/2009 | CN101411828A External use medicament for treating varicose vein of lower limb |
| 04/22/2009 | CN101411821A Anti-aging medicament for treating coronary heart disease and hyperlipemia, and preparation method thereof |
| 04/22/2009 | CN101411812A Pharmaceutical formulation of Chinese white olive for relieving cough and preparation method thereof |